AptarGroup, Inc. develops drug delivery and consumer-product dosing, dispensing and protection technologies for pharmaceutical, beauty, food, beverage, personal care and home care markets. News about ATR commonly covers operating results across Pharma, Beauty and Closures, demand trends in prescription drug delivery, biologics, injectables, nasal delivery, fragrance dispensing and closure applications.
Company updates also include product introductions such as inverted lidless dispensing closures using SimpliSqueeze® valve technology, Aptar Pharma delivery systems used in clinical-stage nasal therapies, Aptar Digital Health partnerships, dividend declarations, share repurchases and investor presentations.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, scheduled for payment on May 18, 2022. The record date for shareholders will be April 27, 2022. A conference call to discuss the first quarter results for 2022 is set for April 29, 2022, at 8:00 a.m. Central Time. Aptar is a leader in drug delivery and consumer product dispensing, employing approximately 13,000 individuals across 20 countries.
AptarGroup, Inc. (NYSE: ATR) announces the sad passing of director Jesse Wu, who served on the Board since 2018 and was part of the Management Development & Compensation Committee. The company expresses deep condolences to his family, highlighting Wu's significant contributions, particularly in the Asian market. Aptar is a global leader in drug delivery and consumer product solutions, with 13,000 employees across 20 countries.
AptarGroup, Inc. (NYSE: ATR) has announced a public offering of $400 million in aggregate principal amount of its 3.600% Senior Notes due 2032. The offering is expected to close on March 7, 2022, pending customary conditions. Proceeds will be used to repay outstanding amounts under its revolving credit facility and for general corporate purposes, including near-term debt repayment. The offering is managed by BofA Securities, HSBC, J.P. Morgan, and Wells Fargo Securities.
Summary not available.
AptarGroup reported robust fourth quarter and annual results for 2021, showcasing a 9% increase in reported sales and a 10% rise in core sales. Annual sales reached a record $3.2 billion, with reported earnings per share climbing 12% to $3.61. The company made strategic acquisitions, including Voluntis and part of Weihai Hengyu Medical Products, enhancing its digital therapeutic and injectable drug delivery capabilities. Despite increased input costs impacting margins, Aptar's commitment to sustainability and cash dividends remains strong, concluding 2021 with $99 million in dividends.
AptarGroup, Inc. (NYSE: ATR) has achieved a Platinum rating from EcoVadis, recognizing its sustainability efforts and placing it in the top 1% of 85,000 companies rated globally. This achievement reflects significant progress from Bronze to Gold and now to Platinum over the last eight years. The rating assesses performance across themes such as environment, labor and human rights, ethics, and sustainable procurement. Aptar’s commitment to sustainability aligns with partners like the Ellen MacArthur Foundation and the United Nations Global Compact.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, payable on February 23, 2022, with a record date of February 3, 2022. The company will host a conference call on February 18, 2022, at 8:00 a.m. CT to discuss its fourth quarter and year-end results for 2021. Additionally, the 2022 Annual Meeting of Stockholders is scheduled for May 4, 2022, at 9:00 a.m. CT, with a record date for voting set for March 11, 2022.
AptarGroup, Inc. (NYSE: ATR) announced the schedule for its quarterly conference calls for the year 2022, with press releases issued after trading hours. Key dates include:
- 4th Quarter and Annual Results: February 17, 2022, with a call on February 18, 2022, at 8:00 a.m. CT
- 1st Quarter Results: April 28, 2022, with a call on April 29, 2022, at 8:00 a.m. CT
- 2nd Quarter Results: July 28, 2022, with a call on July 29, 2022, at 8:00 a.m. CT
- 3rd Quarter Results: October 27, 2022, with a call on October 28, 2022, at 8:00 a.m. CT
Summary not available.
Summary not available.